Clinical research sites are critical in the process of executing a clinical trial and bringing new medications to market. Pharmaceutical companies rely heavily on research site staff to manage the bulk of the effort, including recruitment, engagement, education,...

Clinical trials often require adjustments to the original protocols at some point during the course of the trial. Whether that need is based on new information learned from patients, A/B testing, or simply the inability to enroll enough patients, it’s almost...

Rapid advancements in technology are spurring disruption in nearly every industry, and the biotech and pharmaceutical markets are no exception. From biosensors and 3D bioprinting to gene editing and tissue engineering, there is no doubt that significant evolution is...

One of the biggest challenges pharmaceutical companies face is getting new medications approved and in the hands of patients as planned. Many times, delays begin in the development phase and can last for years with variant after variant falling short of expectations...

The speed at which a clinical trial is completed can mean the difference between ‘first to market’ and a ‘me too’ product for pharmaceutical companies, and the resulting financial implications can be astronomical. Numerous requirements can make it difficult to enlist...